Empire Biotechnologies

Leveraging novel integrin biology for first-in-class gastrointestinal therapeutics.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Albany, NY, US
  • Currency USD
  • Founded April 2013
  • Employees 2
  • Incorporation Type C-corp
  • Website empirebiotechnologies.com

Company Summary

Empire Biotechnologies is a preclinical startup using recent advances in integrin biology to develop novel therapeutics for rare and extreme gastrointestinal diseases. Empire’s lead candidate is an orally delivered protein, EMP-0219, capable of significantly increasing absorption of nutrients in the intestine.

https://www.youtube.com/watch?v=Pk7mdzujE5E

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free